3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Terminated
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Genitourinary
1
Conditions
Disease
1
Carcinoma, Renal Cell
1
Interventions
obinutuzumab
1
ioflupane
1
idelalisib
1
daratumumab
1
alovudine
1
Vindesine
1
Vincristine
1
Rituximab
1
Prednisone
1
Positron Emission Tomography Computed Tomography
1
Mitomycin
1
Magnetic Resonance Spectroscopy
1
Lenalidomide
1
Ga(III)-DOTATOC
1
Doxorubicin
1
Dexamethasone
1
Cyclophosphamide
1
Bleomycin
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Terminated
×
Disease
×
ioflupane
×
Clear all
NCT03185182
2019-06-21
RCCSCAN
Region Skane
Phase 2
Terminated
5 enrolled
5 charts